Genomics England reaches 100,000th genome sequencing milestone

From Crick and Watson onwards, Britain has led the world in this amazing technology. ... positions outside Britain after the country leaves the EU.

UK science could be 'crippled' by a hard Brexit

new survey showing half of the Institute's staff are more likely to seek positions outside of Britain post-Brexit.

Brexit medicine stockpiling could cost £2bn

group Best for Britain.

Sanofi latest to reveal Brexit stockpiling of drugs

Sanofi conducts its ‘batch testing’ quality control checks on the continent but has two manufacturing site in Britain, a cross-border process which would no longer be feasible if a hard

Brexit rebels win vote on European Medicines Agency alignment

Is the Life Sciences Industrial Strategy the right prescription for Britain’s life science sector..

Is flexible working the future?

A glut of research in recent years has already busted this ‘mum myth’ being perpetuated by those who fail to see the obvious – that the majority of Britain’s workforce now ... work-life balance. In fact, a study of 3, 000 UK adults, the largest

30 Women Leaders in UK Healthcare

America) and is leading it at a hugely exciting but challenging time for Britain’s pharma sector.

Brexit Means Brexit

Their importance may be exposed by Brexit. “For example, a company may currently be manufacturing a product in Britain where it’s registered for use in four indications,” says Jonathan. ... However, as part of Brexit, that company may decide it no

Legal and regulatory affairs

Pulling together

It’s the best cluster in Europe. So there’s a challenge here for Europe - because, quite frankly, if scientists move from Britain they ain’t going to Paris and

UCB appoints new managing director of Britain and Ireland

Steve Turley joins from Lundbeck

Gopa Mitra retires from PAGB

She steps down after 34 years at organisation. Gopa Mitra is to retire from the Proprietary Association of Great Britain (PAGB) after 34 years at the organisation.

GSK's Lawson elected PAGB president

The Proprietary Association of Great Britain (PAGB), which represents OTC companies in the UK, has elected Carlton Lawson of GlaxoSmithKline (GSK) as its new president.

MHRA announces senior appointment

McGuire's career has also seen him involved with a number of professional bodies, including the Association of Anaesthetists of Great Britain and Ireland, the Royal College of Anaesthetists and the

Steve Arnold joins UCB from Gilead

Appointed managing director for the British and Irish Isles. UCB has appointed Steve Arnold as managing director for Great Britain and Ireland.

Artificial Intelligence in Healthcare

1. Industrial Strategy: Building a Britain fit for the future [White Paper].

Training the next generation of biotech leaders

In June 2016 the UK voted to leave the EU, prompting a new direction for Britain’s industrial strategy and a sharp focus on biotech and life sciences – fuelled by leading

Clinical and Diagnostics Center

We collaborate with foreign companies from the France, Germany, USA, Great Britain, Switzerland, Spain, Sweden, Poland, Latvia, Croatia, Russia.

Synergy Vision

Synergy Vision believe in delivering medical communications that make a difference to healthcare professionals and patients. Our synergy of pharma and agency experience means that we understand our clients and can deliver bespoke medical

New insights into making behavioural change work

References.  1.      World Health Organization. Noncommunicable diseases (fact sheet 355). Available at: . Accessed February 2018.  2.      NHS Choices. Britain: ‘the fat man of Europe’.